Lurasidone: a new drug in development for schizophrenia

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

(2009) S. M. Stahl et al.   ACTA PSYCHIATRICA SCANDINAVICA

Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity

(2009) Ruggero Galici et al.   BEHAVIOURAL PHARMACOLOGY

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

(2009) Gerhard Gründer et al.   NATURE REVIEWS DRUG DISCOVERY

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia

(2008) Somaia Mohamed et al.   AMERICAN JOURNAL OF PSYCHIATRY

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

(2008) Anantha Shekhar et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

(2008) Stefan Leucht et al.   AMERICAN JOURNAL OF PSYCHIATRY

Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative

(2008) Cameron S. Carter et al.   BIOLOGICAL PSYCHIATRY

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD

(2008) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Schizophrenia: Moving Beyond Monoamine Antagonists

(2008) P. J. Conn et al.   MOLECULAR INTERVENTIONS

Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets

(2007) Alvin V. Terry et al.   BEHAVIOURAL BRAIN RESEARCH

Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats

(2007) T ENOMOTO et al.   BEHAVIOURAL BRAIN RESEARCH

Inactivation of the 5-HT7 Receptor Partially Blocks Phencyclidine-Induced Disruption of Prepulse Inhibition

(2007) Svetlana Semenova et al.   BIOLOGICAL PSYCHIATRY